Used in the treatment of moderate to severe plaque psoriasis, particularly for patients who have not responded well to other systemic therapies. It targets the interleukin-17 receptor, helping to reduce inflammation and skin cell overproduction characteristic of psoriasis. Also being studied for use in psoriatic arthritis due to its strong anti-inflammatory effects.